{"pmid":32313971,"title":"Ventilation of COVID-19 patients in intensive care units.","text":["Ventilation of COVID-19 patients in intensive care units.","Herz","Mohlenkamp, Stefan","Thiele, Holger","32313971"],"journal":"Herz","authors":["Mohlenkamp, Stefan","Thiele, Holger"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313971","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s00059-020-04923-1","source":"PubMed","topics":["Prevention","Treatment"],"weight":1,"_version_":1664714520074911745,"score":8.518259,"similar":[{"pmid":32255489,"title":"Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.","text":["Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.","Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.","Clin Infect Dis","Perinel, Sophie","Launay, Manon","Botelho-Nevers, Elisabeth","Diconne, Eric","Louf-Durier, Aurore","Lachand, Raphael","Murgier, Martin","Page, Dominique","Vermesch, Regine","Thierry, Guillaume","Delavenne, Xavier","32255489"],"abstract":["Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen."],"journal":"Clin Infect Dis","authors":["Perinel, Sophie","Launay, Manon","Botelho-Nevers, Elisabeth","Diconne, Eric","Louf-Durier, Aurore","Lachand, Raphael","Murgier, Martin","Page, Dominique","Vermesch, Regine","Thierry, Guillaume","Delavenne, Xavier"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255489","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cid/ciaa394","source":"PubMed","topics":["Treatment"],"weight":1,"locations":["optimal"],"e_drugs":["Hydroxychloroquine"],"_version_":1664640769801060355,"score":65.06075},{"pmid":32278367,"pmcid":"PMC7146718","title":"COVID-19: Respiratory support outside the intensive care unit.","text":["COVID-19: Respiratory support outside the intensive care unit.","Lancet Respir Med","McEnery, Tom","Gough, Ciara","Costello, Richard W","32278367"],"journal":"Lancet Respir Med","authors":["McEnery, Tom","Gough, Ciara","Costello, Richard W"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278367","week":"202016|Apr 13 - Apr 19","doi":"10.1016/S2213-2600(20)30176-4","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664636873206661120,"score":63.134785},{"pmid":32208493,"title":"Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs).","text":["Recommendations for the admission of patients with COVID-19 to intensive care and intermediate care units (ICUs and IMCUs).","Swiss Med Wkly","Swiss Society Of Intensive Care Medicine","32208493"],"journal":"Swiss Med Wkly","authors":["Swiss Society Of Intensive Care Medicine"],"date":"2020-03-26T11:00:00Z","year":2020,"_id":"32208493","week":"202013|Mar 23 - Mar 29","doi":"10.4414/smw.2020.20227","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352133746950144,"score":61.473568},{"pmid":32051072,"title":"[Emergency response plan for the neonatal intensive care unit during epidemic of 2019 novel coronavirus].","text":["[Emergency response plan for the neonatal intensive care unit during epidemic of 2019 novel coronavirus].","2019 novel coronavirus (2019-nCoV) infection has been spreading in China since December 2019. Neonates are presumably the high-risk population susceptible to 2019-nCoV due to immature immune function. The neonatal intensive care unit (NICU) should be prepared for 2019-nCoV infections as far as possible. The emergency response plan enables the efficient response capability of NICU. During the epidemic of 2019-nCoV, the emergency response plan for the NICU should be based on the actual situation, including diagnosis, isolation, and treatment, as well as available equipment and staffing, and take into account the psychosocial needs of the families and neonatal care staff.","Zhongguo Dang Dai Er Ke Za Zhi","32051072"],"abstract":["2019 novel coronavirus (2019-nCoV) infection has been spreading in China since December 2019. Neonates are presumably the high-risk population susceptible to 2019-nCoV due to immature immune function. The neonatal intensive care unit (NICU) should be prepared for 2019-nCoV infections as far as possible. The emergency response plan enables the efficient response capability of NICU. During the epidemic of 2019-nCoV, the emergency response plan for the NICU should be based on the actual situation, including diagnosis, isolation, and treatment, as well as available equipment and staffing, and take into account the psychosocial needs of the families and neonatal care staff."],"journal":"Zhongguo Dang Dai Er Ke Za Zhi","date":"2020-02-14T11:00:00Z","year":2020,"_id":"32051072","week":"20207|Feb 10 - Feb 16","source":"PubMed","topics":["Diagnosis","Treatment","Prevention"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875308777472,"score":58.892197},{"pmid":32267979,"title":"COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","text":["COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.","As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine.","Pharmacotherapy","Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P","32267979"],"abstract":["As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.(1, 2) However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).(3) The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.(4) This has created an unprecedented situation for emergency and critical care medicine."],"journal":"Pharmacotherapy","authors":["Stringer, Kathleen A","Puskarich, Michael A","Kenes, Michael T","Dickson, Robert P"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267979","week":"202015|Apr 06 - Apr 12","doi":"10.1002/phar.2394","keywords":["covid-19","corona virus","intensive care unit","acute respiratory distress syndrome (ards)"],"source":"PubMed","topics":["Treatment"],"weight":1,"locations":["United States","US","China"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"_version_":1664637635984883712,"score":58.257427}]}